ASH 2023: Exploring Therapeutic Advancements for Chronic Lymphocytic Leukemia - Episode 8
Faculty provide insights into the selection of BTK inhibitors, emphasizing the role of efficacy, toxicity, and quality of life data in treatment decisions, and exploring the impact of MAIC data.